295 related articles for article (PubMed ID: 24274510)
1. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
2. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
3. Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
Khan SA; Patil KS; Yeole PG
Pharmazie; 2008 May; 63(5):348-51. PubMed ID: 18557417
[TBL] [Abstract][Full Text] [Related]
4. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
Bari NK; Fazil M; Hassan MQ; Haider MR; Gaba B; Narang JK; Baboota S; Ali J
Int J Biol Macromol; 2015 Nov; 81():49-59. PubMed ID: 26210037
[TBL] [Abstract][Full Text] [Related]
5. Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
AAPS PharmSciTech; 2006 Jan; 7(1):E8. PubMed ID: 16584167
[TBL] [Abstract][Full Text] [Related]
6. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
7. Buspirone Hydrochloride Loaded In Situ Nanovesicular Gel as an Anxiolytic Nasal Drug Delivery System: In Vitro and Animal Studies.
Abdelnabi DM; Abdallah MH; Elghamry HA
AAPS PharmSciTech; 2019 Mar; 20(3):134. PubMed ID: 30830481
[TBL] [Abstract][Full Text] [Related]
8. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
Shah B; Khunt D; Misra M; Padh H
Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
10. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
Ramreddy S; Janapareddi K
Drug Dev Ind Pharm; 2019 Jan; 45(1):147-158. PubMed ID: 30230386
[TBL] [Abstract][Full Text] [Related]
11. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
13. Microemulsion based intranasal delivery system for treatment of insomnia.
Porecha S; shah T; Jogani V; Naik S; Misra A
Drug Deliv; 2009 Apr; 16(3):128-34. PubMed ID: 19514972
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin.
Wang S; Chen P; Zhang L; Yang C; Zhai G
J Drug Target; 2012 Dec; 20(10):831-40. PubMed ID: 22934854
[TBL] [Abstract][Full Text] [Related]
15. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
17. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
18. The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride.
Tsai YH; Chang JT; Chang JS; Huang CT; Huang YB; Wu PC
J Pharm Sci; 2011 Jun; 100(6):2358-65. PubMed ID: 21246563
[TBL] [Abstract][Full Text] [Related]
19. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
[TBL] [Abstract][Full Text] [Related]
20. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]